Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes

Last updated: November 4, 2025
Sponsor: Yale University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes And Hypertension

Pancreatitis

Diabetes Prevention

Treatment

Self-monitoring

Exercise program

Clinical Study ID

NCT06967701
2000039977
K01DK129441
  • Ages 30-65
  • All Genders

Study Summary

The challenges of living with type 1 diabetes often stand in the way of getting enough exercise. Continuous blood sugar monitoring has revolutionized type 1 diabetes care but remains underutilized to sustainably support exercise and related behaviors. This remote participation-based research will develop a mobile application that delivers personalized encouragement and data-driven health insights based upon patterns in blood sugar, exercise, mood, and sleep, to assist people with type 1 diabetes in exercising more frequently and confidently. You do not need to live in Connecticut to participate, as there will be no required in-person visits during the study.

Eligibility Criteria

Inclusion

Inclusion criteria:

  • 30-65 years old inclusive

  • Diagnosis with type 1 diabetes (T1D) or other insulin deficiency diabetes (latentautoimmune disease of adulthood, diabetes secondary to pancreatitis)

  • Less than 1.0 exercise sessions per week

  • Smartphone ownership

  • English literacy

  • Under regular care by a healthcare provider (1+ appointments per year)

  • Home Broadband wireless Internet or cell phone network

  • Using continuous glucose monitor (CGM) and sharing data with medical record for atleast 6 weeks

  • Using insulin pump or pen and sharing data with medical record for at least 6 weeks

Exclusion

Exclusion criteria:

  • Diabetic ketoacidosis not clearly related to pump site failure in past 6 months

  • >1 episode of severe hypoglycemia (altered mental and/or physical status requiringassistance from another person for recovery) in past 6 months

  • A1c ≥10.0%

  • Resting blood pressure >160mmHg systolic or >100 mmHg diastolic.

  • Myocardial infarction or angina in past 12 months

  • Uncontrolled arrhythmia (e.g., atrial fibrillation with rapid ventricular response,new onset atrial fibrillation, ventricular tachycardia, escape rhythms)

  • Congestive heart failure (stage 3 or 4)

  • Exercise-induced asthma (not controlled on inhalers)

  • Chronic obstructive pulmonary disease (requiring home oxygen)

  • Renal failure

  • Pregnancy

  • Cognitive impairment

  • Severe retinopathy or neuropathy.

  • Other chronic disease or physical disability that would influence exerciseintervention (e.g., recent spinal surgery)

Study Design

Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Self-monitoring
Phase:
Study Start date:
July 10, 2025
Estimated Completion Date:
July 31, 2027

Connect with a study center

  • Yale School of Medicine

    New Haven 4839366, Connecticut 4831725 06510
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.